IO Biotech raises 11 Million Euro in a Series A Financing Round

Jan 5, 2016

Copenhagen, Denmark – January 5, 2016:  IO Biotech today announced the successful completion of a €11 million Series A financing round. Participants were new investor Lundbeckfonden as well as existing investor Novo A/S.

Other news

IO Biotech Announces Appointment of Devin Smith as General Counsel

IO Biotech Announces Appointment of Devin Smith as General Counsel

IO Biotech Provides Business Update

IO Biotech Provides Business Update